SYNCOM FORMULATIONS (INDIA)
Back to Cashflow Statement
|
SYNCOM FORMULATIONS (INDIA) Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2017 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹23 Cr | ₹-5.96 Cr | ₹11 Cr | ₹16 Cr | ₹14 Cr |
What is the latest Cash Flow from Operating Activities ratio of SYNCOM FORMULATIONS (INDIA) ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2025 | ₹23 Cr |
| Mar2024 | ₹-5.96 Cr |
| Mar2023 | ₹11 Cr |
| Mar2022 | ₹16 Cr |
| Mar2017 | ₹14 Cr |
How is Cash Flow from Operating Activities of SYNCOM FORMULATIONS (INDIA) Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹23 Cr | Positive | |
| Mar2024 | ₹-5.96 Cr | Negative | |
| Mar2023 | ₹11 Cr | -35.52 | |
| Mar2022 | ₹16 Cr | 17.98 | |
| Mar2017 | ₹14 Cr | - | |
Compare Cash Flow from Operating Activities of peers of SYNCOM FORMULATIONS (INDIA)
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SYNCOM FORMULATIONS (INDIA) | ₹1,273.7 Cr | 4.2% | -3.1% | -26.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹406,615.0 Cr | 4% | -4.9% | -2.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹159,943.0 Cr | 1.1% | -9.3% | 9.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹133,336.0 Cr | -1.3% | -3.7% | 24% | Stock Analytics | |
| CIPLA | ₹107,499.0 Cr | 1.5% | -9.3% | -7.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,590.0 Cr | 5% | -0.1% | 3.3% | Stock Analytics | |
SYNCOM FORMULATIONS (INDIA) Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SYNCOM FORMULATIONS (INDIA) | 4.2% |
-3.1% |
-26.1% |
| SENSEX | 3.5% |
-1.7% |
7.8% |
You may also like the below Video Courses